399 related articles for article (PubMed ID: 29429376)
41. Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.
Turker P; Turkeri L
Arch Esp Urol; 2013 Nov; 66(9):833-40. PubMed ID: 24231293
[TBL] [Abstract][Full Text] [Related]
42. Can bladder preservation therapy come to the center stage?
Inamoto T; Ibuki N; Komura K; Juri H; Yamamoto K; Yamamoto K; Fujita K; Nonomura N; Narumi Y; Azuma H
Int J Urol; 2018 Feb; 25(2):134-140. PubMed ID: 29171098
[TBL] [Abstract][Full Text] [Related]
43. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
[TBL] [Abstract][Full Text] [Related]
44. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
[TBL] [Abstract][Full Text] [Related]
45. The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis.
Haas CR; Barlow LJ; Badalato GM; DeCastro GJ; Benson MC; McKiernan JM
J Urol; 2016 Jun; 195(6):1704-9. PubMed ID: 26807928
[TBL] [Abstract][Full Text] [Related]
46. Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: results from a multicenter retrospective study.
Nishiyama N; Kitamura H; Hotta H; Takahashi A; Yanase M; Itoh N; Tachiki H; Miyao N; Matsukawa M; Kunishima Y; Taguchi K; Masumori N
Jpn J Clin Oncol; 2014 Nov; 44(11):1101-8. PubMed ID: 25139163
[TBL] [Abstract][Full Text] [Related]
47. [Urethral recurrence of invasive carcinoma following BCG treatment for bladder Ca in situ].
Ruoppolo M; Gozo M; Milesi R; Spina R; Fragapane G
Urologia; 2010; 77 Suppl 17():72-7. PubMed ID: 21308679
[TBL] [Abstract][Full Text] [Related]
48. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
Huguet J
Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
[TBL] [Abstract][Full Text] [Related]
49. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
Soloway MS; Lee CT; Steinberg GD; Ghandi AA; Jewett MA
Urol Oncol; 2007; 25(4):338-40. PubMed ID: 17628304
[TBL] [Abstract][Full Text] [Related]
50. Treatment of high-risk, non-muscle-invasive bladder cancer.
Lerner SP
Nat Clin Pract Urol; 2006 Aug; 3(8):398-9. PubMed ID: 16902498
[No Abstract] [Full Text] [Related]
51. [pT1G3 bladder carcinoma: parameters of a correct therapy].
Ruoppolo M; Dell'Orto P; Fenice O; Seveso M; Ferri P; Zaatar C; Tagliaferri A; Cogni M; Bellorofonte G; Tombolini P
Arch Ital Urol Androl; 1996 Feb; 68(1):17-20. PubMed ID: 8664914
[TBL] [Abstract][Full Text] [Related]
52. Neoadjuvant therapy for muscle-invasive bladder cancer.
Jain RK; Sonpavde G
Expert Rev Anticancer Ther; 2020 Jul; 20(7):603-614. PubMed ID: 32546025
[TBL] [Abstract][Full Text] [Related]
53. [Bladder carcinoma].
Lycklama à Nijeholt AA
Ned Tijdschr Geneeskd; 1992 Jun; 136(23):1097-102. PubMed ID: 1603169
[No Abstract] [Full Text] [Related]
54. [Organ-sparing treatment of bladder cancer].
Niedworok C; Shaleva A; Rübben H; Stenzl A
Urologe A; 2016 May; 55(5):609-14. PubMed ID: 27119956
[TBL] [Abstract][Full Text] [Related]
55. Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.
Novotny V; Froehner M; Ollig J; Koch R; Zastrow S; Wirth MP
Urol Int; 2016; 96(2):136-41. PubMed ID: 26789626
[TBL] [Abstract][Full Text] [Related]
56. [pT1G3 tumor of the bladder].
Vicini D; Bettaglio G; Dallera P; Ruggieri M; Mirando P; Franceschetti GP; Sali C; Picchio GL
Arch Ital Urol Androl; 1996 Feb; 68(1):61-5. PubMed ID: 8664925
[TBL] [Abstract][Full Text] [Related]
57. Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution.
Varol C; Thalmann GN; Burkhard FC; Studer UE
J Urol; 2004 Sep; 172(3):937-42. PubMed ID: 15311003
[TBL] [Abstract][Full Text] [Related]
58. [Treatment of bladder cancer in the elderly].
Fröhner M; Rübben H
Urologe A; 2015 Apr; 54(4):510-5. PubMed ID: 25794588
[TBL] [Abstract][Full Text] [Related]
59. [Therapy and follow-up of bladder cancer].
Meyer D; Schmid HP; Engeler DS
Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413
[TBL] [Abstract][Full Text] [Related]
60. Trimodal therapy for muscle-invasive bladder cancer.
Mathes J; Rausch S; Todenhöfer T; Stenzl A
Expert Rev Anticancer Ther; 2018 Dec; 18(12):1219-1229. PubMed ID: 30324833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
